Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
The Mini-Cog test can return false positive results—meaning it suggests cognitive impairment when none actually exists—and this happens more frequently than many people realize. A person might score poorly on the Mini-Cog due to stress, poor sleep, depression, or simply a bad day, leading to an unnecessary diagnosis of mild cognitive impairment or dementia. Understanding when and why the Mini-Cog produces misleading results is essential for anyone undergoing this screening or caring for someone else who has received a concerning result.
False positives occur because the Mini-Cog, while quick and useful, is a blunt instrument. It measures only three specific cognitive tasks—word recall, clock drawing, and the ability to recognize attention problems—and it cannot account for the full complexity of how a person’s brain works on any given day. A patient with significant anxiety, for example, might perform poorly on recall not because of dementia, but because anxiety disrupts memory formation and retrieval. Similarly, someone who is deaf, has a tremor, or speaks English as a second language may score low on the clock-drawing portion without having cognitive decline.
Table of Contents
- What Exactly Is the Mini-Cog and Why Do False Positives Happen?
- The Real Consequences of False Positive Mini-Cog Results
- Which Patients Are Most Vulnerable to False Positive Mini-Cog Results?
- How to Improve the Accuracy of Mini-Cog Results and Avoid False Positives
- Common Pitfalls in Mini-Cog Administration That Lead to False Positives
- What to Do After an Abnormal Mini-Cog Result
- The Future of Cognitive Screening and Reducing False Positives
- Conclusion
- Frequently Asked Questions
What Exactly Is the Mini-Cog and Why Do False Positives Happen?
The Mini-Cog is a three-minute screening test designed to quickly identify people who may have cognitive impairment and need further evaluation. It consists of three components: the patient repeats and later recalls three words, draws an analog clock showing a specific time, and the clinician assesses whether the patient’s attention is intact. A score of 0-2 is considered “abnormal” and suggests possible cognitive impairment, while a score of 3 is considered normal. False positives emerge because this brief snapshot cannot capture all the variables affecting performance. Consider a 72-year-old woman who takes medications that cause drowsiness, hasn’t slept well in three days, and is anxious about the test itself. She might forget one word, draw the clock hands slightly off, and score 2—technically “abnormal”—yet have no actual cognitive disease.
Her poor performance reflects transient factors, not dementia. This is fundamentally different from someone whose test performance reflects genuine, progressive cognitive decline caused by Alzheimer’s disease or another dementia. The test also doesn’t measure reasoning, judgment, language ability, or visuospatial skills with the depth that more comprehensive neuropsychological testing provides. It is explicitly designed as a screening tool, not a diagnostic tool. Many clinicians and patients mistakenly treat a Mini-Cog result as a diagnosis rather than a reason to investigate further. This confusion is a primary driver of harm from false positives.
The Real Consequences of False Positive Mini-Cog Results
When someone receives a false positive Mini-Cog result—and especially when a clinician presents it as a dementia diagnosis—psychological consequences follow immediately. Many patients experience anxiety, depression, and a sudden decline in confidence and independence. Some become convinced they are “losing their mind” and withdraw from social activities, even though their cognitive abilities are intact. This self-fulfilling prophecy can actually impair their mental health and performance on subsequent tests. False positives also trigger unnecessary medical workups. A patient with an abnormal Mini-Cog might undergo expensive neuroimaging (MRI, PET scan), neuropsychological testing, genetic testing for apolipoprotein E (APOE), and bloodwork—many of these invasive or costly.
When no disease is found, the relief is real, but the patient has already endured months of uncertainty and the financial and emotional burden of investigation. Some patients are prescribed dementia medications (cholinesterase inhibitors, memantine) based on a false positive Mini-Cog result, exposing them to side effects they do not need. A specific clinical example illustrates this: a 68-year-old man scores low on a Mini-Cog in his primary care office during allergy season when he’s sleep-deprived from congestion, and his doctor refers him to neurology. After six months and thousands of dollars in testing, a neuropsychologist determines he has no cognitive impairment—his performance was affected entirely by sleep deprivation and stress about a pending retirement decision. Yet during those six months, he told everyone he had early dementia, avoided his grandchildren out of shame, and experienced significant depression. The false positive itself caused measurable harm.
Which Patients Are Most Vulnerable to False Positive Mini-Cog Results?
Certain populations are at higher risk of false positive Mini-Cog results because their life circumstances, health conditions, or characteristics can impair performance independently of dementia. Patients with depression score poorly on cognitive screening tests across the board—depression slows processing speed, impairs attention, and disrupts memory—yet depression is treatable and reversible. A 75-year-old woman with untreated depression might score 1 on the Mini-Cog, receive a dementia diagnosis, and only later discover that treating her depression with an antidepressant and therapy restores her cognitive function completely. Patients with hearing loss, vision problems, or limited English proficiency are also vulnerable. The Mini-Cog relies on clear communication and the ability to see and interpret the clock-drawing task.
Someone who is deaf and communicates via sign language but underwent testing through a non-signing interpreter may score poorly because the test question was not clearly understood. Likewise, someone learning English as a second language might struggle with word recall or understanding the clock instruction, not because of dementia, but because of language processing time. Patients taking benzodiazepines, opioids, or other sedating medications frequently perform poorly on cognitive screening. So do patients with untreated sleep apnea, chronic pain, thyroid dysfunction, B12 deficiency, or urinary tract infections—all of which can cause cognitive slowing that looks like dementia but is entirely reversible. A 79-year-old man on a newly prescribed blood pressure medication that causes drowsiness, who also has a mild UTI (which he doesn’t know about), might score very low on a Mini-Cog administered during a routine physical, leading to unnecessary dementia evaluation.
How to Improve the Accuracy of Mini-Cog Results and Avoid False Positives
The single most important step in reducing false positives is to treat the Mini-Cog as a screening tool, not a diagnosis. When someone scores abnormally, the appropriate next step is not to diagnose dementia but to investigate why—and investigate thoroughly. A clinician should spend time with the patient and family, asking about recent changes in cognition, function, and health. They should review medications, sleep, mood, medical history, and social factors. They should consider whether the poor performance fits with what family members observe in daily life.
If the history and context suggest the low Mini-Cog score may be a false positive—the patient’s spouse says “nothing is wrong with him, he managed our taxes last month,” or the patient was exhausted and anxious during the test—the appropriate response is to retest a few weeks later under better circumstances, not to order an expensive brain scan. Alternatively, a referral to a neuropsychologist for comprehensive cognitive testing can clarify whether the patient actually has cognitive impairment. Neuropsychological testing takes several hours, involves multiple subtests that measure different cognitive domains, and is much less vulnerable to situational factors than a three-minute bedside screening tool. A practical example: a 70-year-old woman scores 1 on a Mini-Cog in her doctor’s office, but her daughter says her mother regularly completes the Sunday crossword, maintains her garden, and volunteers at the library. Rather than ordering an MRI, the doctor should retest the Mini-Cog in two weeks and, if still abnormal, refer to neuropsychology. Many such cases resolve to normal scores on repeat testing or comprehensive evaluation, preventing unnecessary labels and treatment.
Common Pitfalls in Mini-Cog Administration That Lead to False Positives
The Mini-Cog is frequently administered incorrectly, and these mistakes increase the rate of false positives. One common error is rushing the test or administering it in a distracting environment—for example, testing a patient in a busy primary care clinic with other staff members interrupting, phones ringing, and doors opening and closing. Such environmental stress impairs performance in people without dementia and inflates false positive rates. Another pitfall is failing to account for sensory limitations. Clinicians sometimes administer the clock-drawing test to patients with significant vision problems or tremors without acknowledging these limitations in interpreting the result.
A patient with Parkinson’s disease might draw a poor clock because of tremor, not because of cognitive impairment. Similarly, the Mini-Cog is not reliably valid in patients with a history of stroke affecting the non-dominant hemisphere, where spatial perception and drawing ability may be impaired without cognitive decline. A third mistake is testing a patient who is unwell or in acute distress. Testing someone in pain, in the midst of an acute illness, during a medication adjustment, or while actively anxious about health problems will produce artificially low scores. One study found that patients screened for cognitive impairment while in the hospital for acute illness performed worse than when retested after recovery—suggesting that many hospital-based Mini-Cog results may be false positives driven by acute illness rather than chronic cognitive disease. Clinicians should avoid screening for dementia during acute medical events and instead wait until the patient has recovered.
What to Do After an Abnormal Mini-Cog Result
If you or a family member receives an abnormal Mini-Cog score, the appropriate response is calm investigation, not alarm. Request that your doctor explain what the score means and, critically, ask whether other tests or observations support the idea that dementia is actually present. Ask questions such as: “Have you noticed actual changes in my memory or thinking in daily life?” “Can you compare this to previous years?” “Have we checked my thyroid, B12, and medications?” “Would it be helpful to retest in a few weeks?” and “Should I see a neuropsychologist for more detailed testing?” An abnormal Mini-Cog should trigger a careful medical evaluation to rule out reversible causes. This includes checking thyroid function, vitamin B12, vitamin D, complete metabolic panel, and a urinalysis to rule out urinary tract infection.
The doctor should review all medications and flag those known to impair cognition. The history should explore mood, sleep, stress, recent medical events, and changes in activities of daily living. Only after these steps should a diagnosis of mild cognitive impairment or dementia be considered. Sometimes, after thorough evaluation, the false positive is recognized and the patient is reassured. Other times, the evaluation confirms mild cognitive impairment—but the patient then has a much clearer understanding of the cause and whether it is likely to be dementia or something else.
The Future of Cognitive Screening and Reducing False Positives
The field of cognitive screening is evolving to include more nuanced, multicomponent assessments and biomarkers that can reduce false positives. Blood tests measuring phosphorylated tau, amyloid-beta, and other proteins can now detect Alzheimer’s disease pathology earlier and more specifically than cognitive testing alone. These biomarkers help distinguish patients with early cognitive changes caused by Alzheimer’s disease from those with normal aging or cognitive changes caused by depression, medication, or other factors.
Going forward, cognitive screening will likely rely less on a single test score and more on a combination of brief cognitive screening, relevant biomarkers, imaging when indicated, and careful clinical history. This multi-method approach will reduce both false positives and false negatives, helping ensure that people who actually have dementia are identified early and treated, while those with false positive results are spared unnecessary diagnosis and treatment. For now, the key message is that a single abnormal Mini-Cog test should not be treated as a dementia diagnosis—it is simply the first step in a more complete evaluation.
Conclusion
False positive Mini-Cog results are common because the test is a brief, context-blind screening tool that cannot account for sleep deprivation, depression, medication effects, sensory limitations, stress, or acute illness. Many patients and some clinicians mistake an abnormal Mini-Cog score for a dementia diagnosis, leading to psychological harm, unnecessary medical workups, and inappropriate treatment. The solution is not to abandon the Mini-Cog—it is useful for raising the question of cognitive impairment—but to recognize its limitations and use abnormal results as a prompt for careful, thorough evaluation rather than as a diagnosis itself.
If you receive an abnormal Mini-Cog result, ask your doctor to explain what it means in the context of your actual daily functioning, retest in a few weeks under ideal conditions, and pursue a comprehensive evaluation including medical workup and neuropsychological testing if indicated. Many false positive results will resolve on repeat testing or broader evaluation, and those that do not can be investigated further with more sophisticated methods. The goal is not speed or ease of diagnosis but accuracy—ensuring that real cognitive impairment is caught while false alarms are distinguished and people are spared unnecessary labels and treatment.
Frequently Asked Questions
Can a person be tired and still score normally on the Mini-Cog?
Yes, absolutely. The Mini-Cog result depends partly on alertness and attention at the time of testing. Someone who is well-rested and in a calm environment may score 3 (normal) on the same day they would have scored 1 or 2 if they had been sleep-deprived or anxious. This is why repeat testing under better conditions is important.
If my Mini-Cog score was low, does that mean I definitely do not have dementia?
An abnormal Mini-Cog does not rule out dementia—it means dementia is possible and further investigation is needed. However, it also does not mean you definitely have dementia. Many people with low Mini-Cog scores have reversible causes of poor performance (depression, medication, thyroid disease) and do not have dementia. Further evaluation is the only way to know.
Should I repeat the Mini-Cog at home to see if I do better?
Retesting at home in a calm, familiar environment can be helpful for your own reassurance, but it should not replace a formal medical evaluation. If you are concerned about cognition, discuss this with your doctor, who can interpret the results in the context of your history and other findings.
Can depression cause a false positive Mini-Cog result?
Yes, depression is one of the most common causes of false positive cognitive screening results. Depression impairs memory, attention, and processing speed—symptoms that look like dementia on a brief test. If you have depression and score low on a Mini-Cog, treatment of the depression may significantly improve your cognitive test scores.
How often should the Mini-Cog be repeated if it was abnormal?
If you score abnormally, your doctor should investigate why and may recommend retesting in 2-4 weeks under optimal conditions. If the score remains low and dementia is suspected, referral to a neuropsychologist or dementia specialist is appropriate. There is no fixed schedule; it depends on the clinical situation.
Is the Mini-Cog accurate for older people, or is it more likely to give false positives?
The Mini-Cog was designed for older adults and is generally reliable in populations over 65. However, older age is also associated with higher rates of medication use, sensory impairment, and medical comorbidities that can impair Mini-Cog performance—making false positives more likely in real-world practice if the test is not interpreted carefully.
